ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

  • Home
  • Antibiotic Awareness Week 2024 Blog 3

Antibiotic Awareness Week 2024


U.S. Antibiotic Awareness Week is November 18th-24th. During this observance, SIDP is highlighting members who promote optimal antibiotic use and combat the threat of antibiotic resistance in impactful and innovative ways. This blog features Melissa O'Neal, BS, PharmD

Combating Antimicrobial Resistance: The Role of ID Pharmacists and a One Health Approach 

Efforts to understand and reduce the spread of antimicrobial resistance (AMR) have elucidated a complex interplay between agricultural practices, climate change, waste contamination and water treatment, and environmental or healthcare-related exposure to antimicrobials.1 Globally, human activity now more than ever accelerates the incidence and acquisition of resistant organisms. The ubiquitous and unyielding nature of AMR, including the myriad of contributing factors, therefore requires a multipronged, team-based solution. Many governing bodies like the Centers for Disease Control and Prevention (CDC) as well as the World Health Organization (WHO) have adopted a One Health approach to tackling AMR. One Health unites several disciplines, including experts on human and animal health, epidemiology and ecology, and coordinates with policymakers to better monitor and combat AMR threats.2,3

ID pharmacists, acknowledged as experts in therapeutics, are uniquely positioned to provide guidance on antimicrobial utilization to ultimately mitigate the emergence of resistance. 4,5 By incorporating evidence-based recommendations, significant interventions can be made to shorten treatment durations or narrow antimicrobial spectrum where appropriate.6 ID pharmacists in turn contribute to the literature as researchers publishing pharmacokinetic and pharmacodynamic studies, clinical outcomes data, and cutting-edge in vitro studies analyzing the interplay between antimicrobials and the microbiome. These efforts work to directly reduce unnecessary antimicrobial exposure and better understand the multifaceted impact of pharmacotherapy on drug resistance.

In addition to therapeutics, ID pharmacists also must recognize current and emerging AMR threats and work with laboratory staff and infection preventionists to identify, contain, and prevent the acquisition of these pathogens. This multidisciplinary approach is what makes ID pharmacists and antimicrobial stewardship programs (ASPs) vital contributors to a One Health solution to tackle AMR. ASPs can engage several other key stakeholders including medical and nursing staff, hospital leadership, and policymakers to enact change not only at the bedside but on a large scale.7,8 The global environment may be changing in accessibility, temperature, and ecology however ID pharmacists and ASPs remain steadfastly well-aligned as part of the team based, One Health fight against AMR.

References

  1. Antimicrobial Resistance in the Environment and the Food Supply: Causes and How It Spreads. Centers for Disease Control and Prevention. Updated November 1, 2024. Accessed November 3, 2024. https://www.cdc.gov/antimicrobial-resistance/causes/environmental-food.html
  2.  About Microbial Ecology. Centers for Disease Control and Prevention. Updated July 31, 2024. Accessed November 3, 2024. https://www.cdc.gov/antimicrobial-resistance/about/about-microbial-ecology.html
  3. About One Health. Centers for Disease Control and Prevention. Update October 30, 2024. Accessed November 3, 2024. https://www.cdc.gov/one-health/about/index.html
  4. Centers for Disease Control and Prevention 2019. Core Elements of Hospital Antibiotic Stewardship Programs. https://www.cdc.gov/antibiotic-use/healthcare/pdfs/hospital-core-elements-H.pdf.
  5. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177. doi:10.1086/510393
  6. Jantarathaneewat K, Montakantikul P, Weber DJ, Nanthapisal S, Rutjanawech S, Apisarnthanarak A. Impact of an infectious diseases pharmacist-led intervention on antimicrobial stewardship program guideline adherence at a Thai medical center. Am J Health Syst Pharm. 2022;79(15):1266-1272. doi:10.1093/ajhp/zxac107
  7. Khadse SN, Ugemuge S, Singh C. Impact of Antimicrobial Stewardship on Reducing Antimicrobial Resistance. Cureus. 2023;15(12):e49935. Published 2023 Dec 4. doi:10.7759/cureus.49935
  8. Antimicrobial stewardship interventions: a practical guide. Copenhagen: WHO Regional Office for Europe;2021. License: CC BY-NC-SA 3.0 IGO.

Melissa O'Neal, BS, PharmD


Melissa O'Neal, BS, PharmD  – Pharmacotherapy Specialist - Infectious Diseases, Tampa General Hospital



Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software